Global Neurorehabilitation Devices Market By Product Type (Neurorobotics, Brain-computer Interface, Wearable devices, and Non-invasive Stimulators), By Indication (Stroke, Multiple Sclerosis, Parkinson’s Disease, Other Indications), By End User (Rehabilitation Centers, Hospitals and Clinics, Other End Users), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

In 2022, the Global Neurorehabilitation Devices Market was valued at USD 1,894 Million, is expected to reach USD 6,076 Million by 2032 and this market is estimated to register the highest CAGR of 12.7%.

There is a rising number of neurological disorders like stroke, multiple sclerosis, and brain injuries. Patients with movement disabilities are on the rise. This progressive treatment method provides functional restoration for patients with movement disabilities. These services are designed to give patients the best environment possible to carry out their daily activities.

These factors are increasing numbers of neurological disorders, increased awareness among patients and care providers, and an increase in the target population (majorly older people) around the globe. An increase in the number of people over 65 has led to an increase in age-related neurological conditions, which in turn has led to an increase in movement disabilities. This would result in a greater demand for neuro-rehab services and devices.

There are some neurological conditions that cannot be treated or have no treatment. Neurorehabilitation is a way to save patients in such situations. It allows them to continue with their daily lives. The incorporation of many technological advances has made these services more efficient and effective in recent years.

*Actual Numbers Might Vary In The Final Report

Key Takeaways

• Neurorehabilitation devices are used to treat conditions like traumatic brain injury, spinal cord injury, stroke, Parkinson’s, multiple sclerosis, cerebral palsy, etc.
• Key product segments include neurorobotic systems, brain-computer interfaces, wearable devices, exoskeletons, and virtual reality systems.
• The global neurorehabilitation devices market was valued at USD 1,894 Million in 2022 and is expected to reach USD 6,076 Million by 2032, growing at a CAGR of 12.7%.
• Key growth factors include increasing prevalence of neurological disorders, growing awareness about neurorehabilitation, and technological advancements in robotic and digital therapy solutions.
• North America held the largest market share in 2022, while Asia-Pacific is poised to grow at the highest CAGR during the forecast period.
• Lightweight and wearable devices along with solutions leveraging virtual reality, game-based therapies, and brain-computer interfaces are emerging neurorehabilitation technology trends.

By Product Analysis

According to the product, the market is divided into neurorobotic systems, brain-computer interfaces, wearable devices, and brain stimulators. In 2022, Neurorobotic systems held the largest market share and are expected to grow at an 18.29% CAGR during the forecast period. The neurorobotic systems segment holds a significant market share of the skull stabilization and fixation systems Market.

It is expected that there will be a similar trend in the future due to technological advancements in robotics and their integration with neuroscience, which will allow for the emergence of next-generation rehabilitation methods. Additionally, technological advances, increasing neurological problems, and the growing geriatric population are major factors driving the neurorobotics segment.

Neurorobotics uses robotics, neurosciences, and machine learning to combine robotics with realistic biological simulations of brains. Neurorobotics systems are based on the principles and functions of the central nervous. Neurorobotics are being driven by the recent developments in this area, such as prosthetics or exoskeletons. The exoskeletons can provide assistance to patients with disabilities and those who have been traumatized. Some of the major manufacturers of exoskeletons or prosthetics include Hocoma AG, Inc. Saebo, Inc., and Bioness. The availability of these systems is expected to result in large revenues.

By Indication Analysis

The Largest Market Share Was Held by Stroke, Which Is Expected to Grow at A High CAGR of 16.87% Over The Forecast Period. 

The market can be divided by Indication into Brain & Spinal Cord Injury (Bilateral Sclerosis), Stroke, Multiple Sclerosis, and Cerebral Palsy. The largest market share was held by stroke, which is expected to grow at a high CAGR of 16.87% over the forecast period. There are many outcomes to stroke, including movement impairment, sensory impairment, and cognitive impairment.

Movement impairment is the most common result of a stroke. Most cases of stroke involve one side of the body being affected, resulting in a disability. Due to an increase in stroke incidence worldwide, rehabilitation robotics technologies have seen an increase in demand.

Stroke is a condition that causes brain cells to die by disrupting blood flow and nutrients. Different consequences can be caused by strokes, including visual impairment, motion impairment, sensory impairment, and cognitive impairment. The most common result of stroke is motion impairment. Most strokes result in a partial disability on one side of the body.

In 2013, stroke was the second leading cause of disability and death worldwide. This condition is more common in people with lifestyle diseases and older people. Due to its high prevalence and incidence, along with leading causes of movement disabilities, the market is the largest.

End-User Analysis

The market data for neurorehabilitation devices has been divided into rehabilitation centers, hospitals, and clinics, as well as home care. Due to an increased patient outflow and the increasing number of services on the ground, hospitals and clinics will hold the largest market share for the forecast period. Additionally, consumers will be focusing on health spending after the COVID-19 phase, which is expected to increase segmental growth.

Rehabilitation centers, hospitals, and clinics. Hospitals held the largest share of this market in 2022. They are anticipated to continue to dominate the forecast period due to the increasing demand for neurorehabilitation in hospitals.

Key Market Segments

By Product

• Neurorobotics
• Brain-computer Interface
• Wearable Devices
• Non-invasive Stimulators

By Indication

• Stroke
• Multiple Sclerosis
• Parkinson’s Disease
• Cerebral Palsy
• Other Indications

By End-User

• Rehabilitation Centers
• Hospitals and Clinics
• Home Care
• Other End-Users

Drivers

In recent years, there has been an increase in the number of neurological disorders. These devices are in high demand due to increasing awareness about health and investment in healthcare. The Centers for Disease Control and Prevention 2015 estimates that approximately 130,000 Americans suffer from fatal strokes each year. The increasing need to decrease strokes has led to an increase in the demand for neurorehabilitation equipment. The United States, the U.K., and Ireland are home to large numbers of Parkinson’s patients.

These countries are known for their extensive use of neurorehabilitation devices which has fueled market growth. Age plays an important role in the development of neurological-related diseases. The market for neurorehabilitation devices is likely to grow in regions that have a higher number of elderly people. Wearable technology, robotics, and nanotechnology are all neurorehabilitation devices that aim to improve the nervous system. This, in turn, reduces disability and increases the daily function of people.

Restraints

The main obstacle to the growth of the market for neurorehabilitation devices is the difficulty of using these devices and their unaffordability, especially in emerging economies and low-income regions like Latin America, Africa, and the Middle East. The global market is also hindered by the inability to find skilled professionals to deal with these devices.

Trends

Rapid Technological Advances to Boost Market Growth

Market expansion will be aided by significant technological advancements and an increase in the aging population. Multiple sclerosis and Parkinson’s Disease will continue to increase, which will limit patient mobility and encourage market expansion. The aging population and the increased effectiveness of neurorehabilitation systems, such as gaming systems, are driving market growth. Industry growth will be robust during the forecast period if there is a faster pace of development.

The industry’s growth is driven by an increase in neurological illness rates, increased patient and care provider awareness, as well as an increase in the target patient population. The industry’s growth is primarily due to the increasing number of seniors, who have increased the incidence of age-related neurological diseases and the prevalence of movement impairments. It is predicted that there will be an increase in demand for effective and adequate neuro-rehab services and tools.

There are some neurological conditions that cannot be completely cured or don’t have any effective treatments. Neurorehabilitation is a way to save patients and allow them to continue with their daily lives. These services have undergone major changes in recent years. This will fuel the market for neurorehabilitation devices during the forecast period.

According to recent WHO studies, the WHO predicts that the number 65 years and older will rise from 7% in 2000 up to 16% by 2050. The UN released data in 2012 that showed there would be 1.13 billion people over 65 by 2022. Because of their weaker immune systems, the aging population is more vulnerable to age-related neurological diseases such as Parkinson’s disease. Due to this, the market for rehabilitation devices will grow over the forecast period.

Due to the aging population and untapped potential, neurorehabilitation equipment will be more in demand in Asian countries like India, China, Japan, and Japan. Immobility is the most common symptom of neurological disorders. As per the American Stroke Association, stroke is the leading cause of disability and the fifth-leading cause of death in the United States. Multiple sclerosis is a condition that affects approximately 2.5 million people around the world, while Parkinson’s disease has an estimated 10 million. These factors have been predicted to increase the global market CAGR in recent years.

Recent years have seen a significant shift in neurorehabilitation thanks to the use of electronic robotics and computer-aided devices. These tools can improve the patient’s response to rehabilitation therapy. This sector is poised for great growth as neurological disorders are increasing in prevalence. This is another reason for the increase in the market revenue for neurorehabilitation devices.

Regional Analysis

North America Region Accounted Significant Share of 41.2% The Global Neurorehabilitation Devices Market

North America is the most considerable region for neurorehabilitation equipment. The increasing prevalence of neurological disorders, increasing geriatric populations, and the superior and more well-equipped healthcare infrastructure are all driving factors for this market’s growth. The North American neuro rehab device market is dominated by Canada and the US. Stroke is the ultimate disability in the US, resulting in more than 130,000 deaths each year. Long-term stroke disorder affects more than 400,000 Canadians.

North America has the majority of major players, including Ekso Bionics Holdings, Inc., Bioness, Inc., Medtronic PLC, Kinova Robotics, NINET, and Bioness, Bionik Laboratories, Inc. North America will see an increase in these treatments due to the fact that they are covered by both medical insurance and out-of-pocket costs.

Asia Pacific market will likely see greater growth. This market is forecast to grow at an average CAGR of 16% over the forecast period. Although there aren’t any monopolized players, the potential for the companies to gain entry into this lucrative market will be expanded by increasing the number of patients with neurological disorders and improving the infrastructure.

A growing awareness of Asian markets and an improving healthcare infrastructure are two key factors driving growth. Due to the potential market, many companies are taking strategic initiatives to expand operations in this area. Hocoma AG, which is based in Switzerland, has entered India to provide neurorehabilitation services.

Key Regions

North America

• The US
• Canada
• Mexico

Eastern Europe

• Russia
• Poland
• The Czech Republic
• Greece
• Rest of Eastern Europe

Western Europe

• Germany
• France
• The UK
• Spain
• Italy
• Portugal
• Ireland
• Austria
• Switzerland
• Benelux
• Nordic
• Rest of Western Europe

APAC

• China
• Japan
• South Korea
• India
• Australia & New Zealand
• Indonesia
• Malaysia
• Philippines
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Colombia
• Chile
• Argentina
• Costa Rica
• Rest of Latin America

Middle East & Africa

• Algeria
• Egypt
• Israel
• Kuwait
• Nigeria
• Saudi Arabia
• South Africa
• Turkey
• United Arab Emirates
• Rest of MEA

Key Players Analysis

To increase their market, share, and revenue, major market players will likely invest heavily in their research and development teams. Market leaders are keen to expand their market presence through participation in various development activities, including new product launches and mergers and acquisitions, increased investment, collaboration with other organizations, and increased involvement with other organizations. A number of prominent leaders are also focused on the growing market for neurorehabilitation devices, offering them at a low cost.

The industry’s primary strategy is to reduce operational costs and increase production. The neurorehabilitation device industry will be able to serve a wider range of end-users over the forecast period by providing products with more functionalities and capabilities. Major players in the neurorehabilitation device market include Abbott Laboratories (US), Ekso BIONICS Holdings Inc. (US), Helius Med Technologies (US), Hocoma AG. (Switzerland), and others. They are striving to expand their customer base by adding new products to their portfolios.

Hocoma AG is committed to high-quality product design and manufacturing while also securing a larger competitive base. They offer a wide range of user-friendly products that are safe and easy to use. This is a benefit for both patients and therapists. All applicable medical legislation and international standards are met by their products. Hocoma works closely with its sales partners to ensure that their products are secure.

Medtronic is a combination of data, artificial intelligence, and their deep understanding of the human body that produces amazing results. Their manufacturing is their main focus. They use data-driven insights to optimize care and personalize therapies in real time. Medtronic’s goal is to provide the best technology for patient care. They reinvent robotic-assisted surgical procedures to reach more patients at the highest level of precision and predictability. The company combines cutting-edge technology with a deep understanding of the human body and cutting-edge medical science in order to create new treatments.

Market Key Players

With the presence of many local and regional players, the market for neurorehabilitation devices is fragmented. Market players are subject to intense competition from top market players, particularly those with strong brand recognition and high distribution networks. To stay on top of the market, companies have gained various expansion strategies such as partnerships and product launches.

• Biometrics Ltd
• Bioness Inc.
• Ectron Limited
• Ekso Bionics
• Abbott
• NEURO REHAB VR
• Rex Bionics Ltd
• ReWalks Robotics
• Kinova Inc.
• Tyromotion GmbH
• Helius Medical Technologies
• Reha Technology AG
• Medtronic
• Saebo, Inc.
• Other Key Players

Recent Development

• In August 2023, ReWalk Robotics Ltd. acquired AlterG, Inc., a manufacturer of anti-gravity systems for physical and neurological rehabilitation in order to expand its portfolio.
• In June 2022: Spine X, Inc., a manufacturer of clinical bioelectric medical devices, announced that their first patient was enrolled in a critical study evaluating the SCONE device. The SCONE study is a critical study that evaluates the safety of SCONE devices for the treatment of neurogenic bladders. This is the first significant study to try non-invasive spinal nerve control techniques for treating neurogenic bladder.
• In June 2020, ReWalk Robotics announced its distribution agreement for two additional neurorahiblitaion products in the US.

Report Scope